Scandium explorers: There’s not many of them but this company made a spectacular find
Nick Sundich, March 15, 2023
Scandium is not a common mineral that ASX explorers prospect for. But WA-focused nickel-copper explorer Golden Mile Resources (ASX:G88) just stumbled across some significant intersections at its Quicksilver project.
No time to do stock research, but you still want to invest?
Stocks Down Under Concierge gives you timely BUY and SELL alerts on ASX-listed stocks!
With price targets, buy ranges, stop loss levels and Sell alerts too.
GET A 3-MONTH FREE TRIAL TO CONCIERGE TODAY
What is Scandium?
Scandium is a transition metal that is used for several purposes including alloys for the aerospace industry, solid oxide fuel cells and specialised lighting.
The US government classifies it as one of 35 so-called ‘critical minerals’. It is a rare mineral in Australia, however.
Geoscience Australia estimated in 2018 that there were 12.14kt in Ore Reserves spread across just four projects in the Eastern States – three in NSW and one in QLD.
However, scandium is more common as a by-product and this is the case at Golden Mile Resources’ Quicksilver project.
Scandium is at Golden Mile’s Quicksilver project
Golden Mile reported significant intersections including wide high-grade zones at >100 ppm (parts per million).
It reported the results were near the surface, widespread and contained within the same footprint of the existing nickel-cobalt resource.
Shares rose over 30% this morning, representing perfect timing for those who have already participated in the company’s current rights offer.
Golden Mile Resources (ASX:G88) share price chart, log scale (Source: TradingView)
Quicksilver has an Indicated and Inferred Resource of 26.3Mt @ 0.64% nickel and 0.04% cobalt containing approximately 168,500 tonnes of nickel metal and 11,300 tonnes of cobalt metal.
Stocks Down Under Concierge gives you timely BUY and SELL alerts on ASX-listed stocks!
With price targets, buy ranges, stop loss levels and Sell alerts too.
GET A 3-MONTH FREE TRIAL TO CONCIERGE TODAY
No credit card needed and the trial expires automatically.
Blog Categories
Get Our Top 5 ASX Stocks for FY25
Recent Posts
Orthocell (ASX:OCC): All systems go for a US market roll out of its flagship Remplir nerve repair product
Orthocell (ASX:OCC) is the latest ASX biotech to obtain FDA approval. Its nerve repair product Remplir was already approved in…
Here’s how tariffs impact the stock market and its investors
Many would be wondering how tariffs impact the stock market and its investors. On ‘Liberation Day‘, the returned President Trump…
What are the oldest companies on the ASX? Here are 5 of them and the secrets to their success!
In this article, we look at 5 of the oldest companies on the ASX. Now, we are not claiming these…